Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 16.4.2021B.Braun Melsungen AG (BME)1344CNutriflex Omega special 56/144 (emu inf 5x1250 ml (vak infúzny viackomorový))16.4.2021O
 16.4.2021B.Braun Melsungen AG (BME)1345CNutriflex Omega special 56/144 (emu inf 5x1875 ml (vak infúzny viackomorový))16.4.2021O
 16.4.2021Zentiva k.s. (ZNT-3)38108Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg filmom obalené tablety (tbl flm 28x300 mg/25 mg (blis.PVC/PVDC/Al))21.4.2021O
 16.4.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-4)50519Mycamine 100 mg prášok na infúzny roztok (plv ifo 1x100 mg (liek.inj.skl.))29.4.2021O
 15.4.2021Pfizer Europe MA EEIG (PFI-BE-3)33753VFEND 50 mg filmom obalené tablety (tbl flm 14x50 mg (blis.PVC/Alu))20.4.2021R
 15.4.2021B.Braun Melsungen AG (BME)1340CNutriflex Omega plus 38/120 (emu inf 5x1250 ml (vak infúzny viackomorový))14.4.2021O
 15.4.2021B.Braun Melsungen AG (BME)1350CNutriflex Omega special bez elektrolytov (emu inf 5x1250 ml (vak infúzny viackomorový))15.4.2021O
 15.4.2021Pierre Fabre Medicament (PFB)80648Javlor 25 mg/ml infúzny koncentrát (con inf 1x10 ml/250 mg (skl.inj.liek.+šedá butyl. zátka))30.4.2021R
 15.4.2021CSL Behring GmbH (CSL)50936Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml (liek.inj.skl.))15.4.2021R
 14.4.2021Pfizer Europe MA EEIG (PFI-BE-3)36856CHAMPIX 1 mg filmom obalené tablety (tbl flm 28x1 mg (blis.Aclar/PVC/Alu v papier.skladačke))21.4.2021R
 14.4.2021TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)3279BPramipexol Teva Pharma 2,62 mg (tbl plg 30x2,62 mg (blis.OPA/Al/PVC/Al))23.4.2021R
 14.4.2021Zentiva a.s. (ZNT-SK-2)41861AGAPURIN SR 400 (tbl plg 50x400 mg (blis.PVC/PVDC/Al))16.4.2021R
 14.4.2021Mylan IRE Healthcare Limited (MYR)32651EpiPen (sol inj 2x2 ml/0,3 mg (amp.inj.skl.))15.4.2021O
 14.4.2021GALVEX, spol. s r.o. (GVX)89611Indometacin 100 Galvex (sup 10x100 mg (strip PVC/LDPE))3.5.2021R
 14.4.2021KRKA, d.d., Novo mesto (KRK-2)02603Co-Valsacor 320 mg/12,5 mg filmom obalené tablety (tbl flm 98x320 mg/12,5 mg (blis.PVC/PE/PVDC/Al))19.4.2021O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)